aTyr Pharma ATYR Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.01M-6.8% | $10.74M+74.7% | $6.15M-64.3% | $17.22M+66.2% | $10.36M-6.3% | ||
| $56.51M-16.8% | $67.94M-19.2% | $84.05M+33.1% | $63.13M-4.3% | $65.99M+8.1% | ||
| $67.58M-15.8% | $80.24M-13.7% | $93.01M+6.3% | $87.49M+5.1% | $83.27M+1.6% | ||
| $4.24M-0.6% | $4.26M-3.7% | $4.43M-2.1% | $4.53M-3.4% | $4.68M-3.4% | ||
| $79.65M-14.4% | $93M-12.8% | $106.65M+5.0% | $101.53M+4.4% | $97.25M+0.4% | ||
| $2.76M-29.2% | $3.89M-4.3% | $4.06M+4.7% | $3.88M+153% | $1.53M-64.6% | ||
| $596K-5.4% | $630K0.0% | $630K+12.1% | $562K+2.2% | $550K+1.7% | ||
| $11.7M-22.8% | $15.15M-3.4% | $15.68M+0.9% | $15.53M+45.4% | $10.68M-28.6% | ||
| $98K0.0% | $98K0.0% | $98K+5.4% | $93K+4.5% | $89K+6.0% | ||
| -$616.96M-1.8% | -$606.16M-2.4% | -$592.2M-4.5% | -$566.46M-3.6% | -$546.93M-2.8% | ||
| $57.93M-14.1% | $67.48M-15.9% | $80.24M+7.2% | $74.85M-0.3% | $75.05M+7.2% | ||
| $79.65M-14.4% | $93M-12.8% | $106.65M+5.0% | $101.53M+4.4% | $97.25M+0.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are aTyr Pharma's total assets?
- aTyr Pharma (ATYR) holds $79.7M in total assets, down 18.1% year over year.
- How much debt does aTyr Pharma have?
- aTyr Pharma carries $12.3M in total debt against $57.9M of shareholders' equity, a debt-to-equity ratio of 0.21.
- How much cash does aTyr Pharma have?
- aTyr Pharma holds $10.0M in cash and equivalents.
- Can aTyr Pharma cover its short-term obligations?
- Its current ratio is 5.78 — current assets exceed current liabilities.
- Where does aTyr Pharma's balance sheet data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
